Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
07/2003
07/17/2003US20030134297 Uses of DC-SIGN and DC-SIGNR for inhibiting hepatitis C virus infection
07/17/2003US20030134284 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/17/2003US20030134282 Quantitative analysis of tissue gene expression; amplification; polymerase chain reaction
07/17/2003US20030134281 Nanomachine compositions and methods of use
07/17/2003US20030134263 Controlling gene expression; transfection of cell
07/17/2003US20030133979 Device for the sustained release of aggregation-stabilized, biologically active agent
07/17/2003US20030133971 Positively charged and neutral lipids facilitates cellular uptake; liposomes
07/17/2003US20030133948 An expression vector, comprising a) coding sequences for i) the viral nucleic acid-binding protein LANA ii) a therapeutic gene, and b) viral nucleic acid to which above viral nucleic acid-binding protein will bind
07/17/2003US20030133947 Polynucleotide vaccine formula against canine pathologies, in particular respiratory and digestive pathologies
07/17/2003US20030133943 Protective recombinant Haemophilus influenzae high molecular weight proteins
07/17/2003US20030133941 Method of separating protective components of bordetella pertussis
07/17/2003US20030133937 Incubating the biological preparation with a saccharide, a glycoconjugate or an antibody that inhibits the binding of malignant cells expressing sialyl Lea or di-sialyl Lea, to endothelial cells expressing a LEC-CAM (selectin)
07/17/2003US20030133935 Administering to the human an effective (tumor necrosis factor)TNF- inhibiting amount of an anti-TNF chimeric antibody, which competitively inhibits binding of TNF to monoclonal antibody cA2
07/17/2003US20030133933 Novel integrin alpha subunit
07/17/2003US20030133930 Administering to a patient having an autoimmune disorder an antibody to a B-cell antigens and a carrier; CD22, CD20, CD19, and CD74 or HLA-DR antigen.
07/17/2003US20030133919 An immunogene therapy for treating diseases associated with excessive interleukin-18 induced immunoreaction; administering a transfected cells, preventing autoimmune and allergic disease
07/17/2003US20030133913 Producing chemokine receptors, inducing antigen by dendritic cells in vitro, for therapeutic or prophylactic purposes
07/17/2003US20030133912 Receptor-targeted adenoviral vectors
07/17/2003US20030133911 Pneumovirus ns proteins antagonising the interferon (ifn) response
07/17/2003US20030133909 An isolated polynucleotide encodes a polypeptide which comprising amino acids able to glycosylation, vaccines as an antitumor agent for treating mammal
07/17/2003US20030133907 Amino acid sequence for treating lung diseases, such as idiopathic pulmonary fibrosis
07/17/2003CA2767061A1 Specific binding agents of human angiopoietin-2
07/17/2003CA2514872A1 Purification and characterization of hla proteins
07/17/2003CA2473226A1 Diagnostics and vaccines for mycrobacterium paratuberculosis infections
07/17/2003CA2472927A1 A novel splice variant of myd88 and uses thereof
07/17/2003CA2472647A1 Mammal prolactin variants
07/17/2003CA2472328A1 Fusion proteins
07/17/2003CA2472282A1 Gene products differentially expressed in cancerous breast cells and their methods of use
07/17/2003CA2472180A1 Hair follicle growth
07/17/2003CA2472111A1 Human mast cell-expressed membrane proteins
07/17/2003CA2472108A1 Binding proteins as biosensors
07/17/2003CA2472049A1 Dominant negative proteins and methods thereof
07/17/2003CA2471889A1 Entrapped binding proteins as biosensors
07/17/2003CA2471874A1 Compositions and methods for hydroxylating epothilones
07/17/2003CA2471840A1 Novel compositions and methods for cancer
07/17/2003CA2471768A1 Body weight gain inhibitor
07/17/2003CA2471737A1 Expression of protective antigens in transgenic chloroplasts and the production of improved vaccines
07/17/2003CA2471719A1 Method of treating apoptosis and compositions thereof
07/17/2003CA2471551A1 Methods to engineer mammalian-type carbohydrate structures
07/17/2003CA2471504A1 Ligand for g-protein coupled receptor gpr43 and uses thereof
07/17/2003CA2471432A1 Nonhuman model animal lacking the ability to control lymphocyte migration
07/17/2003CA2470012A1 Novel proteins and nucleic acids encoding same
07/17/2003CA2469177A1 Insulin-responsive dna binding protein-1 and methods to regulate insulin-responsive genes
07/17/2003CA2468888A1 Common lymphatic endothelial and vascular endothelial receptor-1 (clever-1) and uses thereof
07/17/2003CA2468700A1 Extended glucagon-like peptide-1 analogs
07/17/2003CA2467084A1 Mutant chromophores/fluorophores and methods for making and using the same
07/17/2003CA2467083A1 Viral capsid assembly intermediates
07/16/2003EP1327688A1 Adenoviruses with enhanced lytic potency
07/16/2003EP1327685A1 Bzip transcripiton factors that controls expression of the storage protein in the rice plant
07/16/2003EP1327684A1 DNAH5 and its use in diagnosis
07/16/2003EP1327639A1 Prediction of cardiovascular disease by genetic polymorphisms in cardiovascular associated genes
07/16/2003EP1327638A1 Novel dendritic cell wall membrane and use thereof
07/16/2003EP1327628A2 Lipidization of hydrophilic molecules
07/16/2003EP1327146A2 Compounds with a branched linker
07/16/2003EP1327144A1 New nmr screening method
07/16/2003EP1327143A1 Crystal structure of bace and uses thereof
07/16/2003EP1326998A2 Cd38 modulated chemotaxis
07/16/2003EP1326997A2 Model for neurodegenerative diseases involving amyloid accumulation
07/16/2003EP1326991A2 Expression vectors and uses thereof
07/16/2003EP1326990A2 Packaging of positive-strand rna virus replicon particles
07/16/2003EP1326987A1 Chimeric cytoplasmic signalling molecules derived from cd137
07/16/2003EP1326983A2 Gene cluster for ramoplanin biosynthesis
07/16/2003EP1326982A2 Basb205 polypeptides and polynucleotides coding therefor
07/16/2003EP1326981A2 Pharmaceutical preparations and methods for inhibiting tumors
07/16/2003EP1326980A2 Methods of treatment using wisp polypeptides
07/16/2003EP1326979A2 Human cyclic nucleotide binding protein
07/16/2003EP1326978A2 Hematopoietin receptors hpr1 and hpr2
07/16/2003EP1326977A2 Human secretin receptor-like gpcr
07/16/2003EP1326976A1 Mfq-114, a human ajuba like protein
07/16/2003EP1326975A2 Regulation of human secretin receptor-like gpcr
07/16/2003EP1326974A2 Methods of using a human il-17-related polypeptide to treat disease
07/16/2003EP1326973A2 Regulation of human gpcr-like protein
07/16/2003EP1326972A2 Transporters and ion channels
07/16/2003EP1326971A2 Proteins and nucleic acids encoding same
07/16/2003EP1326970A2 Rapid profiling of the interactions between a chemical entity and proteins in a given proteome
07/16/2003EP1326963A2 Nucleic acid amplification controls
07/16/2003EP1326961A2 Compositions and methods for inducing specific cytolytic t cell responses
07/16/2003EP1326895A1 Monoclonal antibodies directed against hepatitis b viruses
07/16/2003EP1326893A2 Plasma fraction containing bikunin, method for the production thereof and use of the same
07/16/2003EP1326892A2 Compositions that inhibit proliferation of cancer cells
07/16/2003EP1326891A1 Gene encoding a human g-protein coupled receptor and its use
07/16/2003EP1326889A1 Nucleotide sequences coding for the suga gene
07/16/2003EP1326888A2 Novel compounds
07/16/2003EP1326887A2 Polypeptide from haemophilus influenza
07/16/2003EP1326886A2 Basb208 nucleotide and amino acid sequences from haemophilus influenzae
07/16/2003EP1326885A2 Novel compounds
07/16/2003EP1326884A2 Regulation of promoter activity using a polypeptide isolated from lactococcus lactis
07/16/2003EP1326882A2 Enterokinase cleavage sequences and their use
07/16/2003EP1326881A1 PREPARATION OF CAPPED mRNA
07/16/2003EP1326879A2 Nucleic acid constructs and cells, and methods utilizing same for modifying the electrophysiological function of excitable tissues
07/16/2003EP1326839A2 Recombinant adenovirus vectors that are replication-competent in tert-expressing cells
07/16/2003EP1326628A2 Chemokine mutants in the treatment of multiple sclerosis
07/16/2003EP1326627A1 Methods of modulating apoptosis by administration of relaxin agonists or antagonists
07/16/2003EP1326626A2 Methods for treating rheumatoid arthritis using il-17 antagonists
07/16/2003EP1326625A1 Immunogenic composition of hepatitis c and methods of use thereof
07/16/2003EP1025231B1 Robo: a family of polypeptides and nucleic acids involved in nerve cell guidance
07/16/2003EP1019510B1 Vaccines derived from porcine circoviruses
07/16/2003EP0975354A4 Ligand/lytic peptide compositions and methods of use
07/16/2003EP0951475B1 Metastatic colorectal cancer vaccine
07/16/2003EP0873353B1 IgG SEPARATION MEDIUM AND PROTEIN A VARIANT
1 ... 1570 1571 1572 1573 1574 1575 1576 1577 1578 1579 1580 1581 1582 1583 1584 1585 1586 1587 1588 1589 1590 ... 2916